ArcanaBio

Reykjavik, Iceland Founded: 2018 • Age: 8 yrs
Real-time biosurveillance for workplaces is enabled through SaaS diagnostics.
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About ArcanaBio

ArcanaBio is a company based in Reykjavik (Iceland) founded in 2018 by Christian Gunnarsson. ArcanaBio offers products and services including Biophotonics Platform and Saliva-based Diagnostics. ArcanaBio operates in a competitive market with competitors including Hememics Biotechnologies, PathSpot, Terragene, Nuverse and ShiUV, among others.

  • Headquarter Reykjavik, Iceland
  • Founders Christian Gunnarsson
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Arcanabio Ehf.
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ArcanaBio

ArcanaBio offers a comprehensive portfolio of products and services, including Biophotonics Platform and Saliva-based Diagnostics.

Product name locked
Category locked
Primary

Platform for saliva-based monitoring of health biomarkers and disease prevention.

Product name locked
Category locked
Locked

Technology enabling everyday access to critical biomarkers for long-term health.

Funding Insights of ArcanaBio

Investors in ArcanaBio

ArcanaBio has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include BioInnovation Institute.

All
Venture Fund
Investor Description Founded Year Domain Location
Life science innovation is advanced by BioInnovation Institute.
Locked Locked Locked
Premium access

Investor details for ArcanaBio

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ArcanaBio

Investments
Premium access

Investment portfolio details for ArcanaBio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - ArcanaBio

Premium access

Detailed financials for ArcanaBio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Arcanabio Comparisons

ArcanaBio Primary company
Description
Real-time biosurveillance for workplaces is enabled through ...
Location
Reykjavik, Iceland
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for ArcanaBio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of ArcanaBio

ArcanaBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hememics Biotechnologies, PathSpot, Terragene, Nuverse and ShiUV, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Biopreservation platform for mammalian cells and biologics is developed.
Locked Locked Locked
Hand scanning devices for detecting harmful contaminants are developed.
Locked Locked Locked
Sterilization products and disinfection systems are supplied for workplaces.
Locked Locked Locked
Provider of an AI and cloud-based patient monitoring and diagnostic tool for healthcare professionals
Locked Locked Locked
Workplace sanitization products, including air sterilization equipment, are supplied.
Premium access

Detailed competitors of ArcanaBio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Arcanabio

Premium access

Complete news archive for ArcanaBio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ArcanaBio

ArcanaBio was founded in 2018 and raised its 1st funding round 6 years after it was founded.

ArcanaBio is headquartered in Reykjavik, Iceland.

Christian Gunnarsson is the current CEO of ArcanaBio. They have also founded this company.

ArcanaBio was founded in 2018 and is headquartered in Reykjavik, Iceland. Operations focus on the biosurveillance sector, where a SaaS platform is utilized for real-time pathogen detection and health monitoring in workplaces. Saliva-based genetic diagnostics are employed to identify and track health risks. Services are delivered digitally to support ongoing surveillance needs in professional environments.

ArcanaBio's top competitors include PathSpot, Hememics Biotechnologies and Nuverse.

ArcanaBio offers Biophotonics Platform and Saliva-based Diagnostics.

ArcanaBio has 1 investor. Key investors include BioInnovation Institute.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available